MicroRNA-340-mediated degradation of microphthalmia-associated transcription factor mRNA is inhibited by the coding...

Area of Science:

• Molecular Biology
• Gene Regulation
• Cancer Biology

Background:

• Alternative cleavage and polyadenylation generate mRNA isoforms with varying 3'-untranslated regions (UTRs).
• These 3'-UTRs influence post-transcriptional regulation through cis-acting elements.
• Microphthalmia-associated transcription factor (MITF) is crucial for melanocyte development and is implicated in melanoma.

Purpose of the Study:

• To investigate the regulation of MITF mRNA isoforms in melanoma.
• To elucidate the role of microRNA-340 (miR-340) and RNA-binding proteins in MITF regulation.

Main Methods:

• Analysis of MITF mRNA 3'-UTR variants in melanoma cells.
• Investigating the interaction between miR-340 and MITF mRNA.
• Studying the effect of coding region determinant-binding protein (CRD-BP) on miR-340 binding and MITF expression.

Main Results:

• Melanoma cells preferentially express MITF mRNA with a shorter 3'-UTR.
• miR-340 targets the MITF 3'-UTR, leading to mRNA degradation and reduced MITF activity.
• CRD-BP binds the MITF 3'-UTR, inhibiting miR-340, stabilizing MITF mRNA, and increasing MITF expression.

Conclusions:

• A novel regulatory mechanism involving miR-340 and CRD-BP controls MITF expression in melanocytes and melanoma.
• This interplay highlights the importance of 3'-UTR length and regulatory factors in melanoma pathogenesis.
• Targeting this pathway could offer therapeutic strategies for melanoma.